CWM
IMUC

Catamount Wealth Management’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Catamount Wealth Management’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-25
Closed – – 192
2016
Q3 		$0 Hold
25
– – ﹤0.01% 179
2016
Q2 		$0 Hold
25
– – ﹤0.01% 151
2016
Q1 		$0 Hold
25
– – ﹤0.01% 150
2015
Q4 		$0 Hold
25
– – ﹤0.01% 171
2015
Q3 		$0 Hold
25
– – ﹤0.01% 234
2015
Q2 		$0 Hold
25
– – ﹤0.01% 216
2015
Q1 		$0 Hold
25
– – ﹤0.01% 202
2014
Q4 		$1K Buy
+25
New +$720 ﹤0.01% 128

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return